Advances in managing obesity

Successful management of obesity requires integration of pharmaceutical agents and bariatric surgeries with traditional lifestyle modifications. Notable developments for managing obesity in 2015 included the demonstration of weight-beneficial outcomes for liraglutide and empagliflozin, and the first 5-year follow-up of patients with type 2 diabetes mellitus and obesity randomly assigned to receive bariatric surgery or conventional medical therapy.